Heartland Advisors Inc. lifted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 36.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,591,750 shares of the medical instruments supplier’s stock after buying an additional 424,400 shares during the period. Heartland Advisors Inc. owned about 0.80% of DENTSPLY SIRONA worth $14,103,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of XRAY. Nykredit A S acquired a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $38,000. Allworth Financial LP acquired a new position in DENTSPLY SIRONA during the second quarter worth about $51,000. IFP Advisors Inc grew its position in DENTSPLY SIRONA by 244.4% during the third quarter. IFP Advisors Inc now owns 5,566 shares of the medical instruments supplier’s stock worth $49,000 after buying an additional 3,950 shares during the period. Public Employees Retirement System of Ohio purchased a new position in DENTSPLY SIRONA in the second quarter valued at about $69,000. Finally, HighTower Advisors LLC purchased a new position in DENTSPLY SIRONA in the third quarter valued at about $90,000. 95.70% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of research firms recently weighed in on XRAY. Barrington Research lowered their price target on DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 26th. Zacks Research cut DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 9th. Mizuho decreased their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Thursday, October 22nd. BMO Capital Markets lowered their target price on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a report on Thursday, September 17th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Friday, October 30th. Three investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus target price of $12.08.
Check Out Our Latest Report on DENTSPLY SIRONA
DENTSPLY SIRONA Stock Performance
Shares of XRAY stock opened at $8.51 on Thursday. The company has a debt-to-equity ratio of 1.47, a quick ratio of 1.04 and a current ratio of 1.63. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of -13.72, a price-to-earnings-growth ratio of 1.26 and a beta of 0.87. DENTSPLY SIRONA Inc. has a one year low of $8.14 and a one year high of $14.76. The company has a 50 day moving average price of $9.29 and a 200 day moving average price of $11.14.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $0.29 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.02). The firm had revenue of $836.00 million during the quarter, compared to analysts’ expectations of $861.68 million. DENTSPLY SIRONA had a positive return on equity of 20.21% and a negative net margin of 3.38%. The business’s revenue for the quarter was down 7.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.37 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. Sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.21 EPS for the current year.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.
Further Reading
- Five stocks we like better than DENTSPLY SIRONA
- Grounded at 52-Week Lows: When Will Boeing Stock Take Flight?
- Apple’s Next Margin Defense Could Be Hiding in Your Wallet
- From Berlin to Brussels: Tesla’s $3.3 Billion Robotaxi Gamble
- Target Stock Is Up Over 70%—Has the Easy Money Already Been Made?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
